{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-027504","form_type":"8-K","ticker":"ZURA","cik":"0001855644","company_name":"Zura Bio Ltd","filed_at":"2025-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.336470+00:00","generated_at":"2026-05-24T06:04:54.958590+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"confidence":"high","headline":"Zura Bio FY 2024 net loss $45.4M ($0.60/sh); cash $176.5M, runway to 2027","bullets":["Cash and cash equivalents $176.5M as of Dec 31, 2024, up from $99.8M at year-end 2023; sufficient to fund operations through 2027.","Net loss improved to $45.4M ($0.60 per share) from $69.2M ($2.09 per share) in 2023.","Initiated Phase 2 TibuSURE trial for tibulizumab in systemic sclerosis (SSc) in Dec 2024; Phase 2 HS trial planned for Q2 2025.","Completed $112.5M private placement in April 2024; also executed warrant exchange and established ATM program in 2024.","Robert Lisicki appointed CEO in April 2024; Kiran Nistala joined as CMO in Jan 2024; Scientific Advisory Board established June 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-027504","json":"https://secwatch.observer/filing/0001104659-25-027504.json","markdown":"https://secwatch.observer/filing/0001104659-25-027504.md","text":"https://secwatch.observer/filing/0001104659-25-027504.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855644/000110465925027504/0001104659-25-027504-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855644/000110465925027504/tm2510115d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T06:04:54.958590+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}